DNAGinkgo Bioworks Holdings, Inc.

NYSE ginkgobioworks.com


$ 0.32 $ 0.05 (19.66 %)    

Thursday, 27-Jun-2024 13:52:40 EDT
QQQ $ 481.56 $ 1.58 (0.33 %)
DIA $ 392.15 $ 1.36 (0.35 %)
SPY $ 546.11 $ 0.62 (0.11 %)
TLT $ 93.63 $ 0.19 (0.21 %)
GLD $ 215.10 $ 0.39 (0.18 %)
$ 0.2839
$ 0.27
$ 0.28 x 200
$ 0.33 x 23,800
$ 0.26 - $ 0.32
$ 0.28 - $ 2.55
135,467,775
na
569.31M
$ 2.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-29-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-13-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-16-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-15-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 05-24-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cathie-woods-ark-invest-acquires-73m-worth-of-shares-in-this-promising-netflix-competitor-sells-off-coinbase-stock-amid-bitcoin-slump

On Wednesday, Cathie Wood-led Ark Invest made significant trades in Roku Inc (NASDAQ:ROKU) and Coinbase Global Inc (NASDAQ:COIN...

 btig-maintains-sell-on-ginkgo-bioworks-holdings-lowers-price-target-to-02

BTIG analyst Mark Massaro maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Sell and lowers the price target from $0.5 to...

 ginkgo-bioworks-says-on-june-17-it-began-implementing-previously-announced-restructuring-with-headcount-reductions-which-it-expects-to-result-in-total-reduction-of-at-least-35-of-workforce-when-all-impacted-employees-have-departed---filing

As previously announced, on May 9, 2024, in connection with the Company’s multi-year plan to reduce operational expenditures, m...

 cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

 investment-advisor-says-throwing-random-darts-at-tickers-would-beat-arkk-as-cathie-woods-flagship-fund-lags-far-behind-soaring-market-how-do-they-do-it

Ram Ahluwalia of Lumida Wealth pointed to Ark's flagship ETF trading over 70% below its all-time high amid the S&P 500&...

 btig-downgrades-ginkgo-bioworks-holdings-to-sell

BTIG analyst Mark Massaro downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.

 morgan-stanley-maintains-equal-weight-on-ginkgo-bioworks-holdings-lowers-price-target-to-1

Morgan Stanley analyst Tejas Savant maintains Ginkgo Bioworks Holdings (NYSE:DNA) with a Equal-Weight and lowers the price t...

 ginkgo-bioworks-receives-notice-of-continued-listing-standard-notice-from-nyse

Ginkgo's Class A Common Stock continues to trade on the NYSEBOSTON, May 13, 2024 /PRNewswire/ -- Ginkgo Bioworks Holdings, ...

 william-blair-downgrades-ginkgo-bioworks-holdings-to-underperform

William Blair analyst Matt Larew downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Market Perform to Underperform.

 ginkgo-bioworks-stock-falls-on-disappointing-q1-sales-this-trend-needs-to-change

Ginkgo Bioworks reported quarterly sales of $38 million which missed the analyst consensus estimate of $46.044 million by 17.47...

 ginkgo-bioworks-holdings-q1-2024-gaap-eps-008-beats-009-estimate-sales-38000m-miss-46044m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of...

 ginkgo-bioworks-holdings-q1-sales-38000m-miss-46044m-estimate

Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly sales of $38.000 million which missed the analyst consensus estimate of ...